Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H33NO3 |
Molecular Weight | 335.4809 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1
InChI
InChIKey=IQADUMSPOQKAAO-UHFFFAOYSA-N
InChI=1S/C20H33NO3/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4/h9-13H,5-8,14-17H2,1-4H3
Molecular Formula | C20H33NO3 |
Molecular Weight | 335.4809 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.drugbank.ca/drugs/DB04822Curator's Comment: Description was created based on several sources, including http://www.fda.gov.ph/consumers-corner/registered-drugs-2/337707-DR-X1387
Sources: http://www.drugbank.ca/drugs/DB04822
Curator's Comment: Description was created based on several sources, including http://www.fda.gov.ph/consumers-corner/registered-drugs-2/337707-DR-X1387
Oxeladin citrate is a cough suppressant, is a highly potent and effective drug used to treat all types of cough of various etiologies. Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity. Oxeladine is a component of antitussive drug, Altussan, approved in Philippines.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.mims.com/philippines/drug/info/altussan
Cap Adult 1 cap. Syr Adult 1 tbsp (15 mL). Childn 1 tsp (5 mL). Infant ¼-½ tsp (1.25-2.5 mL). All doses to be taken 3 hrly.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:58 GMT 2023
by
admin
on
Fri Dec 15 15:12:58 GMT 2023
|
Record UNII |
SNC1080T5Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QR05DB09
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
||
|
WHO-ATC |
R05DB09
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C170272
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
CHEMBL1500276
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
4619
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
C005461
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
Oxeladin
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
SNC1080T5Y
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
468-61-1
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
m8299
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | Merck Index | ||
|
2018
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
DB04822
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
207-412-1
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
SUB09513MIG
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
677
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
100000083056
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | |||
|
32626
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID0048343
Created by
admin on Fri Dec 15 15:12:58 GMT 2023 , Edited by admin on Fri Dec 15 15:12:58 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|